MOSCOW, September 16. /TASS/. The partners of the Russian Direct Investment Fund (RDIF) for the production of the Sputnik vaccine in South Korea are getting ready to start the mass supply of the drug to the global market, a spokesperson with RDIF told TASS.

"The partners of RDIF for contract production of the Sputnik vaccine in South Korea are getting ready to start the large-scale supply of the drug to the global market. The ceremony of shipping the first batch of Sputnik Light will be held in the near future in the presence of the RDIF leadership and GL Rapha," the official said.

Russia’s Sputnik vaccine against COVID-19 is also produced by pharmaceutical companies in India, China, Argentina and other countries. In particular, one of the RDIF production partners is Serum Institute of India.